Search Results for: prempro

Published on:

A federal court in Connecticut kept alive a Prempro breast cancer wrongful death case, denying Wyeth’s pretrial motion for summary judgment. Plaintiffs’ brought the classic Prempro case against Wyeth who makes the hormone therapy drugs Premarin, an estrogen, and Prempro, a combination of Premarin and a progestin, which are both prescribed to combat the symptoms […]

Published on:

MassTortDefense Blog posted about the U.S. Supreme Court decision to not hear a punitive damages case, Wyeth v. Scroggin. In the first trial, bifurcated on liability and damages, the jury held the drug company responsible to the tune of $2.7 million in compensatory damages, and then $19.4 million in punitive damages. Appeals predictably followed, and […]

Published on:

The Associated Press reports yesterday’s decision by the 8th U.S. Circuit Court of Appeals (St. Louis) that overruled a 2008 federal district court opinion precluding remand of hormone therapy suits to Minnesota state court. The appellate court also held that the dismissal of lawsuits then pending in Little Rock was erroneous. The holding was premised […]

Published on:

Bloomberg has a nice article on a 2007 case against Pfizer over its drug Prempro (the drug was manufactured by Wyeth, but Pfizer recently purchased Wyeth). The plaintiff in that Philadelphia state court case, Mary Daniel, took the drug for 16 months and argued that it caused her to develop breast cancer. The jury in […]

Published on:

In the first hormone therapy trial since the Connie Barton case where the jury awarded $3.7 million in compensatory damages and an undisclosed amount in punitive damages (the specific amount has been posted in unconfirmed reports on the web), a second Philadelphia jury has determined that Pfizer (which purchased Wyeth, the original manufacturer of the […]

Posted in:
Published on:
Updated:
Published on:

Last month brought changes to sixty-five (65) medical product labels (up from 63 changes in February), with changes to the prescribing information to include any of the following areas: boxed warnings, contraindications, warnings, precautions, adverse reactions, patient package insert, and medication guide. For a complete detailed accounting of the label changes, please refer to the […]

Published on:

Since Monday, there have been decisions in two hormone therapy cases. Here are the details: Monday, February 22-Audrey Singleton: In the Philadelphia Court of Common Pleas, a jury found for the Plaintiff and against Pfizer/Wyeth. The verdict, which came after a four-hour deliberation, was for $9.45 million ($3.25 in compensatory damages and $6 million in […]

Posted in:
Published on:
Updated:
Published on:

It will be a great year. If one of your new year’s resolutions is to follow industry news more closely, here’s some required reading: Hormone Therapy: Bloomberg reports on the latest Plaintiff’s Prempro victory (actually, the drug at issue here was Provera, later combined with Premarin by Wyeth to make Prempro)—a Pennsylvania appeals court ruled […]

Published on:

Fresh from two record losses in Philadelphia state court over Prempro, Pfizer is reacting to plaintiffs’ lawyers posting of a video on YouTube. We uploaded a copy of that video in our November 24th blog post and have embedded it below.